Download App

Log in to access Online Inquiry
Company Overview More
Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. The company operates in two segments, Network and Hospital. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. The company’s other treatments and diagnostic services comprise computed tomography scanners. In addition, it provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, the company offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, it operates specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of December 31, 2021, it operated a network of 16 cooperative centers based in 13 hospitals. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People’s Republic of China.
CEO: Yang, Jianyu
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

CCM Concord Medical Services
1.390-0.030-2.11%
YOY
Do not show
Hide blank lines
(FY)2021/12/31(Q4)2021/12/31(Q2)2021/06/30(FY)2020/12/31
Assets
Current assets
Cash, cash equivalents and short term investments
-52.92% 157.39M -- 157.39M -56.46% 246.65M 349.84% 334.26M
-Cash and cash equivalents
-52.92% 157.39M -- 157.39M -56.46% 246.65M 349.84% 334.26M
Receivables
36.61% 383.04M -- 383.04M -11.86% 89.73M 40.5% 280.39M
-Accounts receivable
65.3% 127.9M -- 127.9M 40.07% 86.18M 4.94% 77.38M
-Loans receivable
151.27% 169.27M -- 169.27M -- -- -3.87% 67.37M
-Accrued interest receivable
-- 0 -- 0 -- -- -94.57% 157K
-Taxes receivable
21.51% 45.25M -- 45.25M -- -- 157.41% 37.24M
-Other receivables
-49.93% 55.48M -- 55.48M -91.19% 3.55M 133.65% 110.79M
-Recievables adjustments allowances
-18.56% -14.85M -- -14.85M -- -- -39% -12.53M
Inventory
76.24% 38.09M -- 38.09M 631.62% 40.77M 397.81% 21.61M
Prepaid assets
-25.89% 2.71M -- 2.71M -22.61% 223.46M -14.45% 3.65M
Restricted cash
-70.24% 1.39M -- 1.39M -- 2.23M -- 4.66M
Current deferred assets
-- 1.87M -- 1.87M -- -- -- --
Other current assets
-- -- -- -- -- -- -- 31.42M
Total current assets
-13.54% 584.48M -- 584.48M -37.38% 602.84M 139.3% 676M
Non current assets
Net PPE
4.64% 3.35B -- 3.35B 32.58% 3.61B 25.66% 3.2B
-Gross PPE
4.25% 3.59B -- 3.59B 32.58% 3.61B 19.57% 3.44B
-Accumulated depreciation
0.87% -241.03M -- -241.03M -- -- 26.97% -243.14M
Goodwill and other intangible assets
124.94% 1.66B -- 1.66B 57.64% 1.16B -0.87% 736.48M
-Goodwill
172.34% 581.88M -- 581.88M 132.94% 498.31M 1.53% 213.66M
-Other intangible assets
105.56% 1.07B -- 1.07B 26.94% 666.31M -1.82% 522.82M
Investments and advances
24.79% 390.63M -- 390.63M -6.25% 301.39M 381.95% 313.02M
Non current accounts receivable
-65.04% 4.8M -- 4.8M -69.35% 6.21M -49.34% 13.72M
Non current prepaid assets
-19.57% 232.2M -- 232.2M -51.71% 324.41M -54.34% 288.7M
Other non current assets
-87.37% 13.58M -- 13.58M 155.01% 34.9M -- 107.47M
Total non current assets
21.19% 5.65B -- 5.65B 21.22% 5.44B 16.03% 4.66B
Total assets
16.79% 6.23B -- 6.23B 10.87% 6.04B 24.13% 5.33B
Liabilities
Current liabilities
Payables
74.47% 282.5M -- 282.5M 7.74% 8.79M -19.66% 161.92M
-accounts payable
450.17% 102.51M -- 102.51M 32.74% 7.95M 125.16% 18.63M
-Total tax payable
126.43% 20.95M -- 20.95M -61.48% 834K 102.32% 9.25M
-Other payable
18.66% 159.04M -- 159.04M -- -- -28.96% 134.03M
Current accrued expenses
21.25% 121.15M -- 121.15M 63.44% 418.59M 22.74% 99.92M
Current debt and capital lease obligation
96.78% 319.84M -- 319.84M -77.34% 126.18M -52.38% 162.54M
-Current debt
101.07% 299.35M -- 299.35M -80.44% 107M -54.67% 148.88M
-Current capital lease obligation
49.95% 20.48M -- 20.48M 94.4% 19.18M 6.03% 13.66M
Current deferred liabilities
-7.65% 81.03M -- 81.03M -- -- 2650.47% 87.74M
Current liabilities
57.1% 804.52M -- 804.52M -32.58% 553.55M -18.38% 512.12M
Non current liabilities
Long term debt and capital lease obligation
10.1% 2.41B -- 2.41B 26.38% 2.3B 45.08% 2.19B
-Long term debt
11.71% 2.2B -- 2.2B 29.33% 2.08B 52.35% 1.97B
-Long term capital lease obligation
-4.14% 214.23M -- 214.23M 3.99% 220.16M 2.13% 223.48M
Non current deferred liabilities
20.27% 184.42M -- 184.42M 1.86% 169.72M -7.31% 153.34M
Non current accrued expenses
-- 75.35M -- 75.35M -- -- -- --
Derivative product liabilities
-- 5.86M -- 5.86M -- -- -- --
Preferred securities outside stock equity
26.33% 3.68B -- 3.68B 24.67% 3.41B 52.58% 2.91B
Other non current liabilities
-95.76% 3.25M -- 3.25M -26.6% 76.73M -26.74% 76.73M
Total non current liabilities
19.25% 6.36B -- 6.36B 23.42% 5.96B 44.57% 5.34B
Total liabilities
22.57% 7.17B -- 7.17B 15.28% 6.51B 35.42% 5.85B
Shareholders'equity
Share capital
0% 105K -- 105K 0% 105K 0% 105K
-common stock
0% 105K -- 105K 0% 105K 0% 105K
Retained earnings
-33.4% -3.28B -- -3.28B -34.16% -2.79B -37.59% -2.46B
Paid-in capital
5.25% 1.94B -- 1.94B 2.72% 1.87B 4.55% 1.84B
Less: Treasury stock
-12.5% 7K -- 7K -12.5% 7K 0% 8K
Gains losses not affecting retained earnings
36.47% -29.5M -- -29.5M 61.41% -40.19M 52.28% -46.43M
Total stockholders'equity
-106.67% -1.37B -- -1.37B -166.17% -955.19M -440.02% -662.96M
Noncontrolling interests
188.49% 433.06M -- 433.06M 203.7% 485.45M 46.6% 150.11M
Total equity
-82.72% -937.06M -- -937.06M -136.02% -469.74M -2417.9% -512.85M
Currency Unit
CNYCNYCNYCNY
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
Unqualified Opinion with Explanation----Unqualified Opinion with Explanation

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%